16 results on '"Ternisien C"'
Search Results
2. Platelet function analyser (PFA-100) results and von Willebrand factor deficiency: a 16-year ‘real-world’ experience
3. Diagnosis and management challenges in patients with mild haemophilia A and discrepant FVIII measurements
4. French cohort of thirty-seven patients with type 3 von Willebrand disease: Molecular and clinical features: PO-MO-258
5. Analysis of the French cohort of sixty-five patients with type 2N von Willebrand disease identifies distinct molecular/clinical entities: PO-MO-257
6. A new class of mutations in the A3 region of von Willebrand factor inducing multiple functional defects in the protein: FP-TU-04.3-1
7. Prophylactic treatment in factor XI deficiency patients undergoing invasive procedures: PO-TU-243
8. Use of thrombin generation assay in the management of hemostatic treatments in a patient with severe factor V deficiency and anti-factor V inhibitor: PO-TU-241
9. The use of the new ReFacto AF laboratory standard (RLS AF) confirms reliable measurement of FVIII:C level by a one-stage clotting assay in ReFacto AF-treated patients: PO-TU-078
10. Patientsʼ opinion surveys are necessary to assess the quality of the organization of a health facility: PO-MO-009
11. Validation of the first commercial ELISA for type 2N von Willebrandʼs disease diagnosis
12. The use of the new ReFacto AF Laboratory Standard allows reliable measurement of FVIII:C levels in ReFacto AF mock plasma samples by a one-stage clotting assay
13. Session M2.2: Distribution of von Willebrand disease (VWD) types in 197 families from the French national reference center for VWD (CRMW): type 1 is not the most frequent within “true” VWD: 35FP01
14. The use of the new ReFacto AF laboratory standard (RLS AF) allows reliable measurement of FVIII:C levels in ReFacto AF mock plasma samples by a one-stage clotting assay: 18P23
15. An accurate and routinely adapted enzyme-linked immunosorbent assay for type 2N von Willebrand disease diagnosis: 08P15
16. Discrepancies between one stage assay and chromogenic substrate assay in patients treated with recombinant or plasma-derived FVIII and usefulness of a specific standard in ReFacto AF®-treated patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.